Table 3 Core needle biopsies with benign findings.
Histologic category | Number | Number excised (%) | No. with correlating benign lesion on excision (%) | No. with malignancy on excision (%) |
|---|---|---|---|---|
Lesions very likely to correlate with architectural distortion | ||||
Sclerosing lesionsa | 186 | |||
Complex sclerosing lesion | 84 | 59 (70%) | 57 (97%) | 1 (2%) 1 DCIS |
Radial sclerosing lesion | 20 | 14 (70%) | 12 (86%) | 0 |
Sclerosing adenosis | 36 | 14 (39%) | 14 (100%) | 0 |
With Atypiab | 27 | 25 (93%) | 21 (84%) | 7 (33%) 5 DCIS/2 invasive |
With ALH/LCIS (classic)c | 19 | 10 (53%) | 7 (70%) | 2 (20%) 1 DCIS/1 invasive |
Other benign findings | 32 | |||
Scarring due to biopsy or traumad | 16 | 5 (31%) | 5 (100%) | 0 |
Cysts with rupturee | 14 | 1 (7%) | 1 (100%) | 0 |
Fat necrosis | 2 | 1 (50%) | 1 (100%) | 0 |
Total (excluding atypia and ALH/LCIS) | 172 | 94 (55%) | 90 (96%) | 1 (1%) |
Lesions that may or may not correlate with architectural distortion | ||||
Nonspecific benign changesf | 81 | 34 (42%) | 13 (38%) | 4 (12%) 4 invasive |
Dense stromag | 68 | 29 (43%) | 15 (52%) | 1 (3%) 1 invasive |
Fibroadenoma/fibroadenomatoid change | 10 | 4 (40%) | 3 (75%) | 1 (25%) 1 invasive |
Papilloma | 1 | 1 | 1 (100%–1.3 cm papilloma) | 0 |
With Atypiah | 12 | 10 (83%) | 2 (17%) | 4 (33%) 2 DCIS/2 invasive |
With ALH/LCIS (classic)i | 14 | 9 (69%) | 4 (44%) | 4 (44%) 2 DCIS/2 invasive |
Total (excluding atypia and LCIS/ALH) | 160 | 68 (43%) | 32 (47%) | 6 (9%) |